Terms: = Leukemia AND Ki-67 AND Clinical Outcome
14 results:
1. clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
Scheubeck G; Jiang L; Hermine O; Kluin-Nelemans HC; Schmidt C; Unterhalt M; Rosenwald A; Klapper W; Evangelista A; Ladetto M; Jerkeman M; Ferrero S; Dreyling M; Hoster E
Leukemia; 2023 Sep; 37(9):1887-1894. PubMed ID: 37495776
[TBL] [Abstract] [Full Text] [Related]
2. Mechanism of Action of Decitabine in the Treatment of Acute Myeloid leukemia by Regulating LINC00599.
Du F; Jin T; Wang L
Anal Cell Pathol (Amst); 2023; 2023():2951519. PubMed ID: 36874552
[TBL] [Abstract] [Full Text] [Related]
3. T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer.
Li H; Yan X; Liu L; Huang L; Yin M; Pan C; Zhang P; Qin H
Biomed Pharmacother; 2017 Apr; 88():924-930. PubMed ID: 28178623
[TBL] [Abstract] [Full Text] [Related]
4. Role of CD204-positive tumor-associated macrophages in adult T-cell leukemia/lymphoma.
Saito Y; Komohara Y; Niino D; Horlad H; Ohnishi K; Takeya H; Kawaguchi H; Shimizu H; Ohshima K; Takeya M
J Clin Exp Hematop; 2014; 54(1):59-65. PubMed ID: 24942947
[TBL] [Abstract] [Full Text] [Related]
5. Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl G; Sahakyan K; Denk U; Girbl T; Alinger B; Hofbauer SW; Neureiter D; Hofbauer JP; Egle A; Greil R; Hartmann TN
PLoS One; 2011; 6(8):e23758. PubMed ID: 21876768
[TBL] [Abstract] [Full Text] [Related]
6. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease.
Palacios F; Moreno P; Morande P; Abreu C; Correa A; Porro V; Landoni AI; Gabus R; Giordano M; Dighiero G; Pritsch O; Oppezzo P
Blood; 2010 Jun; 115(22):4488-96. PubMed ID: 20233972
[TBL] [Abstract] [Full Text] [Related]
7. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
Giannopoulos K; Mertens D; Bühler A; Barth TF; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
Leukemia; 2009 Mar; 23(3):519-27. PubMed ID: 19092852
[TBL] [Abstract] [Full Text] [Related]
8. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract] [Full Text] [Related]
9. Expression of cyclins D1, D2, and D3 and ki-67 in leukemia.
Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
[TBL] [Abstract] [Full Text] [Related]
10. Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.
Schrader C; Meusers P; Brittinger G; Teymoortash A; Siebmann JU; Janssen D; Parwaresch R; Tiemann M
Leukemia; 2004 Jul; 18(7):1200-6. PubMed ID: 15116121
[TBL] [Abstract] [Full Text] [Related]
11. Expression of functional markers in acute lymphoblastic leukemia.
Oh EJ; Kahng J; Kim Y; Kim M; Lim J; Kang CS; Min WS; Cho B; Lee A; Lee KY; Kim WI; Shim SI; Han K
Leuk Res; 2003 Oct; 27(10):903-8. PubMed ID: 12860010
[TBL] [Abstract] [Full Text] [Related]
12. [Expression of cyclin-dependent kinase inhibitors in leukemia].
Polák J; Peková S; Schwarz J; Kozák T; Haskovec C
Cas Lek Cesk; 2003 Jan; 142(1):25-8. PubMed ID: 12693294
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic value of ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
Yamanaka N; Harabuchi Y; Kataura A
Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
[TBL] [Abstract] [Full Text] [Related]
14. clinical relevance of immunocytochemical detection of multidrug-resistance-associated P-glycoprotein in hematologic malignancies.
Musto P; Cascavilla N; Di Renzo N; Ladogana S; La Sala A; Melillo L; Nobile M; Matera R; Lombardi G; Carotenuto M
Tumori; 1990 Aug; 76(4):353-9. PubMed ID: 1975959
[TBL] [Abstract] [Full Text] [Related]
